India’s First Indigenous Drug for Sickle Cell Disease
Recently, an Indian pharmaceutical company announced the development of a new drug for Sickle Cell Disease (SCD).
Key Points
- It is India’s first indigenous hydroxyurea oral solution, which is used for the treatment of sickle cell disease in children.
- The drug would be the country’s first indigenous, room temperature stable drug for sickle cell disease to be available at only 1% of the global price.
- The drug will be provided to the government at the cost of Rs. 600, which is nearly 1% of the cost of the medicine currently available globally at Rs. 77,000.
- Oral syringes would be provided for precise dosage ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 India Philanthropy Report 2025
- 2 “Imagine a World with More Women in Science’’ Campaign
- 3 Swavalambini: Empowering Women Entrepreneurs
- 4 BIMSTEC Youth Summit 2025
- 5 NHRC’s Core Group Meeting on ASHAs
- 6 Concerns of PwDs over DPDP Rules
- 7 Nari Adalats: Women-only Courts for Alternative Dispute Resolution
- 8 NITI Aayog’s Workshop on Enabling Women-Led Development through Entrepreneurship
- 9 India Hosts First-Ever Regional Dialogue on Social Justice
- 10 Revised Guidelines on Obesity Diagnosis & Treatment
